Whilst we have many similarities in our DNA, there are considerable genetic variations that make each one of us unique. With today's technological advances, it is fast becoming a global imperative to ensure that medicines are tailored to our specific physiology and needs. As a medical doctor, I am convinced that precision medicine holds huge potential for patients, offering better targeted treatment, avoiding medical errors, and reducing adverse reactions to medicines. More research is needed for its successful uptake in our health systems, and a key element in making this happen is to maximise the possibilities of big data in health 1 . Big data has enormous potential to advance medical research, bring about greater innovation in healthcare, and improve the overall performance of health systems. However, there are a number of barriers to fully capturing and making full use of the considerable health data we have in the EU, notably fragmentation of data sets and insufficient computing infrastructure to connect Europe's eHealth systems.
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.
Biomed Hub 2017;2(suppl 1) :479406 ( DOI: 10.1159/000479406 ) Andriukaitis: Personalised Medicine in Europe: Foreword from the EU Commissioner for Health and Food Safety www.karger.com/bmh guidelines for treatment, and, crucially, more effective, innovative, and personalised treatments.
The potential of the ERN model has been widely recognised, and I want to do my part to ensure that the practical application of these "virtual" networks runs as smoothly as possible so that they can be scaled up and extended to other diseases. We are supporting the Networks, for example, with European cross-border telemedicine tools and via a range of EU funding mechanisms.
In parallel, the Commission is working to ensure the interoperability of eHealth systems. The eHealth Network, since it was formally set up in 2011, has made great strides. Now, Member States are working together to set up the necessary digital architecture to exchange health data, starting with ePrescriptions and Patient Summaries, across borders. So far 16 EU countries are benefitting from EU financing under the Connecting Europe Facility (CEF) for this purpose, and we expect a number of the remaining countries to apply for financing before the end of 2017.
Also before the end of 2017, the Commission intends to table a Communication specifically on digital health and care, following recommendations laid out in the mid-term review of the Digital Single Market Strategy published this May. Amongst other suggestions, this paper will urge EU countries to support the development of a secure data infrastructure to advance research, disease prevention, and personalised health and care.
I have highlighted two areas where the European Commission is focusing efforts to help ensure that big data can be used to provide more efficient and personalised healthcare for patients. I am certain that many interesting ideas will be explored at the EAPM congress "Personalising Your Health." I look forward to hearing about the outcomes, and to exploring together how we can further ensure that big data can be used for better care of Europe's patients.
